Portfolio (Quarterly)
Guide ↗
Ishara Investments LP
· CIK 0002111609| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 164,000.0 | $6.1M | 4.47% | NEW | — | $37.11 | -10.2% |
| 2 | INSM | INSMED INC | Healthcare | 51,250.0 | $5.5M | 4.01% | NEW | — | $106.62 | +11.2% |
| 3 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 143,500.0 | $5.4M | 3.94% | NEW | — | $37.42 | +126.7% |
| 4 | TNXP | TONIX PHARMACEUTICALS HLDG C | Healthcare | 338,250.0 | $4.3M | 3.17% | NEW | — | $12.76 | +6.5% |
| 5 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 57,400.0 | $4.3M | 3.14% | NEW | — | $74.48 | +2.8% |
| 6 | KURA | KURA ONCOLOGY INC | Healthcare | 276,750.0 | $3.0M | 2.23% | NEW | — | $10.97 | +15.4% |
| 7 | CYTK | CYTOKINETICS INC | Healthcare | 32,800.0 | $2.8M | 2.05% | NEW | — | $85.19 | -15.4% |
| 8 | NUVB | NUVATION BIO INC | Healthcare | 369,000.0 | $2.1M | 1.54% | NEW | — | $5.68 | +17.3% |
| 9 | WVE | WAVE LIFE SCIENCES LTD | Healthcare | 328,000.0 | $1.9M | 1.40% | NEW | — | $5.81 | -13.3% |
| 10 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 26,650.0 | $1.9M | 1.37% | NEW | — | $69.81 | +3.9% |
| 11 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 32,800.0 | $1.7M | 1.22% | NEW | — | $50.75 | +14.0% |
| 12 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 2,460.0 | $1.2M | 0.90% | NEW | — | $496.73 | +9.1% |
| 13 | SPRY | ARS PHARMACEUTICALS INC | Healthcare | 143,490.0 | $1.1M | 0.84% | NEW | — | $8.01 | -26.5% |
| 14 | — | MONOPAR THERAPEUTICS INC | — | 12,300.0 | $1.1M | 0.84% | NEW | — | $92.59 | — |
| 15 | ERAS | ERASCA INC | Healthcare | 41,000.0 | $751K | 0.55% | NEW | — | $18.32 | -1.6% |
| 16 | MREO | MEREO BIOPHARMA GROUP PLC | Healthcare | 768,750.0 | $244K | 0.18% | NEW | — | $0.32 | -20.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%